Gene Therapy R & D

Butterfly Sciences has three product goals for an HIV/AIDS rescue system. This should be able to bring a person in late stage back from the edge.
This consists of an HIV – Synthetic vaccine system, an anti-aging GHRH gene therapy and a system for knockout of HIV in the chromosomes.

The HIV synthetic vaccine produces intra-cellular antibodies to HIV proteins. The knockout system can disrupt replication of the HIV virus an and immunize the cell against it.

GHRH gene therapy can return this master hormone in the body to youthful levels, generating youthful condition in many ways. GHRH affects the immune system, cognition, cardiac muscle health, strength, endurance, and rate of healing. For HIV, this hormone compensates for the way GP120 on the outside of the HIV virus, removing GHRH from circulation.

Safety – The type of gene therapy that most people are familiar with is delivered by engineered viruses. That method is appropriate for many applications. The principal scientist at Butterfly Sciences has studied the problems of gene therapy treatment in detail. The immunology of gene therapy can be problematic, leading to grave illness and death. Viral methods are much more likely to cause shock syndromes.

The preferred method of gene therapy in some cases is plasmid therapy. This method is often reversible if necessary by removing the small region of muscle where the gene therapy has been administered.



2 thoughts on “Gene Therapy R & D

  1. Brian, Have you made any progress on the GHRH therapy. Read that there are 6 thousand HIV survivors in San Francisco that are now facing the usual aging diseases. Hard to believe that you could not get funded for such a promising new therapy. I had a transplant at Stanford Dec 2017 so I have some interest in restoring my immune system. Please let me know if yo have a board with updates. Thanks

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.